Published in Acta Biomater on July 23, 2010
In vivo evaluation of electrospun polycaprolactone graft for anterior cruciate ligament engineering. Tissue Eng Part A (2015) 2.04
Electrospun scaffolds for tissue engineering of vascular grafts. Acta Biomater (2013) 1.17
Tropoelastin: a versatile, bioactive assembly module. Acta Biomater (2013) 0.91
Mechanical property characterization of electrospun recombinant human tropoelastin for vascular graft biomaterials. Acta Biomater (2011) 0.90
Natural and Genetically Engineered Proteins for Tissue Engineering. Prog Polym Sci (2012) 0.87
Tissue Engineering of Blood Vessels: Functional Requirements, Progress, and Future Challenges. Cardiovasc Eng Technol (2011) 0.83
Elastomeric Recombinant Protein-based Biomaterials. Biochem Eng J (2013) 0.81
The Tissue-Engineered Vascular Graft-Past, Present, and Future. Tissue Eng Part B Rev (2015) 0.79
Biomechanical Comparison of Glutaraldehyde-Crosslinked Gelatin Fibrinogen Electrospun Scaffolds to Porcine Coronary Arteries. J Biomech Eng (2016) 0.79
Elastin-coated biodegradable photopolymer scaffolds for tissue engineering applications. Biomed Res Int (2014) 0.77
Evaluation of polycaprolactone scaffold with basic fibroblast growth factor and fibroblasts in an athymic rat model for anterior cruciate ligament reconstruction. Tissue Eng Part A (2015) 0.77
Extracellular matrix molecules facilitating vascular biointegration. J Funct Biomater (2012) 0.77
Fabricated Elastin. Adv Healthc Mater (2015) 0.76
Use of protein-engineered fabrics to identify design rules for integrin ligand clustering in biomaterials. Integr Biol (Camb) (2015) 0.76
Athymic rat model for evaluation of engineered anterior cruciate ligament grafts. J Vis Exp (2015) 0.76
Pericyte Seeded Dual Peptide Scaffold with Improved Endothelialization for Vascular Graft Tissue Engineering. Adv Healthc Mater (2016) 0.76
Scaffolds in vascular regeneration: current status. Vasc Health Risk Manag (2015) 0.76
Biomechanics and biocompatibility of the perfect conduit-can we build one? Ann Cardiothorac Surg (2013) 0.76
Vascular replacement using a layered elastin-collagen vascular graft in a porcine model: one week patency versus one month occlusion. Organogenesis (2015) 0.75
Small Diameter Blood Vessels Bioengineered From Human Adipose-derived Stem Cells. Sci Rep (2016) 0.75
Blended Polyurethane and Tropoelastin as a Novel Class of Biologically Interactive Elastomer. Tissue Eng Part A (2016) 0.75
Elastomers in vascular tissue engineering. Curr Opin Biotechnol (2016) 0.75
Fabrication and Characterization of Electrospun Thermoplastic Polyurethane/Fibroin Small-Diameter Vascular Grafts for Vascular Tissue Engineering. Int Polym Process (2016) 0.75
Elastin-PLGA Hybrid Electrospun Nanofiber Scaffolds for Salivary Epithelial Cell Self-Organization and Polarization. Acta Biomater (2017) 0.75
Electrospun silk fibroin-gelatin composite tubular matrices as scaffolds for small diameter blood vessel regeneration. J Mater Sci Mater Med (2017) 0.75
Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer. J Clin Oncol (2009) 5.88
Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol (2008) 2.98
The ARCH Projects: design and rationale (IAASSG 001). Eur J Cardiothorac Surg (2013) 2.06
Transapical wire-assisted endovascular repair of thoracic aortic dissection. J Endovasc Ther (2011) 2.04
Elastin. Adv Protein Chem (2005) 1.82
A sex-specific role for androgens in angiogenesis. J Exp Med (2010) 1.78
Electrospun protein fibers as matrices for tissue engineering. Biomaterials (2005) 1.72
Coronary artery bypass grafting with and without manipulation of the ascending aorta--a meta-analysis. Heart Lung Circ (2011) 1.70
Decorin prevents metastatic spreading of breast cancer. Oncogene (2005) 1.69
Substrate elasticity provides mechanical signals for the expansion of hemopoietic stem and progenitor cells. Nat Biotechnol (2010) 1.66
Three-dimensional and two-dimensional quantitative coronary angiography, and their prediction of reduced fractional flow reserve. Eur Heart J (2010) 1.58
Prognostic features of long-term survivors after surgical management of malignant pleural mesothelioma. Ann Thorac Surg (2009) 1.54
Intracoronary shear-related up-regulation of platelet P-selectin and platelet-monocyte aggregation despite the use of aspirin and clopidogrel. Blood (2010) 1.52
Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: a meta-analysis of randomized and nonrandomized studies. J Thorac Cardiovasc Surg (2010) 1.47
Aortic valve-sparing operations in aortic root aneurysms: remodeling or reimplantation? Interact Cardiovasc Thorac Surg (2011) 1.47
Molecular basis of elastic fiber formation. Critical interactions and a tropoelastin-fibrillin-1 cross-link. J Biol Chem (2004) 1.42
Fibulin-5 interacts with fibrillin-1 molecules and microfibrils. Biochem J (2005) 1.41
Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices. J Am Coll Cardiol (2005) 1.39
Biomaterials derived from silk-tropoelastin protein systems. Biomaterials (2010) 1.36
A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Oncol (2010) 1.34
Synthetic elastin hydrogels derived from massive elastic assemblies of self-organized human protein monomers. Biomaterials (2004) 1.32
Cell adhesion to tropoelastin is mediated via the C-terminal GRKRK motif and integrin alphaVbeta3. J Biol Chem (2009) 1.30
Shape of tropoelastin, the highly extensible protein that controls human tissue elasticity. Proc Natl Acad Sci U S A (2011) 1.29
Tropoelastin. Int J Biochem Cell Biol (2008) 1.23
Animal models for the assessment of novel vascular conduits. J Vasc Surg (2010) 1.19
A meta-analysis of deep hypothermic circulatory arrest versus moderate hypothermic circulatory arrest with selective antegrade cerebral perfusion. Ann Cardiothorac Surg (2013) 1.19
Fibrillin-1 interactions with heparin. Implications for microfibril and elastic fiber assembly. J Biol Chem (2005) 1.19
Transcatheter aortic valve implantation for high-risk patients with severe aortic stenosis: A systematic review. J Thorac Cardiovasc Surg (2009) 1.18
The emerging role of the thioredoxin system in angiogenesis. Arterioscler Thromb Vasc Biol (2010) 1.18
Lumen loss in the first year in saphenous vein grafts is predominantly a result of negative remodeling of the whole vessel rather than a result of changes in wall thickness. Circulation (2006) 1.15
Consensus on hypothermia in aortic arch surgery. Ann Cardiothorac Surg (2013) 1.13
Cell therapies for therapeutic angiogenesis: back to the bench. Vasc Med (2009) 1.12
The influence of elasticity and surface roughness on myogenic and osteogenic-differentiation of cells on silk-elastin biomaterials. Biomaterials (2011) 1.11
Serum biomarkers of neurologic injury in cardiac operations. Ann Thorac Surg (2012) 1.08
Coacervation of tropoelastin. Adv Colloid Interface Sci (2010) 1.08
Rare non-synonymous variations in the transcriptional activation domains of GATA5 in bicuspid aortic valve disease. J Mol Cell Cardiol (2012) 1.07
Summary of prognostic factors and patient selection for extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma. Ann Surg Oncol (2011) 1.05
Elastin-based materials. Chem Soc Rev (2010) 1.04
Survivor treatment selection bias and outcomes research: a case study of surgery in infective endocarditis. Circ Cardiovasc Qual Outcomes (2009) 1.04
Specificity in the coacervation of tropoelastin: solvent exposed lysines. J Struct Biol (2005) 1.04
Highly Elastic Micropatterned Hydrogel for Engineering Functional Cardiac Tissue. Adv Funct Mater (2013) 1.04
Integrin alpha v beta 3 binds a unique non-RGD site near the C-terminus of human tropoelastin. Biochimie (2004) 1.03
Tailoring the porosity and pore size of electrospun synthetic human elastin scaffolds for dermal tissue engineering. Biomaterials (2011) 1.03
Thoracic endovascular aortic repair--indications and evidence. Ann Thorac Cardiovasc Surg (2011) 1.03
Cellular interactions with elastin. Pathol Biol (Paris) (2005) 1.02
Degradation of tropoelastin by matrix metalloproteinases--cleavage site specificities and release of matrikines. FEBS J (2010) 1.02
Severe burn injuries and the role of elastin in the design of dermal substitutes. Tissue Eng Part B Rev (2011) 1.01
Primary human dermal fibroblast interactions with open weave three-dimensional scaffolds prepared from synthetic human elastin. Biomaterials (2009) 0.99
Synthesis of highly porous crosslinked elastin hydrogels and their interaction with fibroblasts in vitro. Biomaterials (2009) 0.99
Cross-linked open-pore elastic hydrogels based on tropoelastin, elastin and high pressure CO2. Biomaterials (2009) 0.99
Hydrogel-coated microfluidic channels for cardiomyocyte culture. Lab Chip (2013) 0.97
Increasing the pore size of electrospun scaffolds. Tissue Eng Part B Rev (2011) 0.97
Covalent immobilisation of tropoelastin on a plasma deposited interface for enhancement of endothelialisation on metal surfaces. Biomaterials (2009) 0.97
The genetic and molecular basis of bicuspid aortic valve associated thoracic aortopathy: a link to phenotype heterogeneity. Ann Cardiothorac Surg (2013) 0.97
Coacervation is promoted by molecular interactions between the PF2 segment of fibrillin-1 and the domain 4 region of tropoelastin. Biochemistry (2005) 0.96
Tcf15 primes pluripotent cells for differentiation. Cell Rep (2013) 0.95
Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study. Diabetes Care (2012) 0.95
Engineered tropoelastin and elastin-based biomaterials. Adv Protein Chem Struct Biol (2009) 0.95
Management of the ascending aorta in patients with bicuspid aortic valve disease. Heart Lung Circ (2008) 0.95
The immobilization of recombinant human tropoelastin on metals using a plasma-activated coating to improve the biocompatibility of coronary stents. Biomaterials (2010) 0.94
Mapping of macrophage elastase cleavage sites in insoluble human skin elastin. Matrix Biol (2008) 0.94
In vitro degradation of human tropoelastin by MMP-12 and the generation of matrikines from domain 24. Matrix Biol (2008) 0.93
Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors. J Thorac Cardiovasc Surg (2009) 0.93
Structural disorder and dynamics of elastin. Biochem Cell Biol (2010) 0.93
Death from pulmonary artery erosion complicating implantation of percutaneous left atrial appendage occlusion device. Heart Rhythm (2013) 0.93
Elastin as a nonthrombogenic biomaterial. Tissue Eng Part B Rev (2011) 0.92
Engineered cell-laden human protein-based elastomer. Biomaterials (2013) 0.92
Tropoelastin--a multifaceted naturally smart material. Adv Drug Deliv Rev (2012) 0.92
Tropoelastin massively associates during coacervation to form quantized protein spheres. Biochemistry (2006) 0.92
Improving survival results after surgical management of malignant pleural mesothelioma: an Australian institution experience. Ann Thorac Cardiovasc Surg (2011) 0.91
A model two-component system for studying the architecture of elastin assembly in vitro. J Struct Biol (2005) 0.91
Tropoelastin bridge region positions the cell-interactive C terminus and contributes to elastic fiber assembly. Proc Natl Acad Sci U S A (2012) 0.91
The relationship between coronary stenosis severity and compression type coronary artery movement in acute myocardial infarction. Am Heart J (2010) 0.91
Haem oxygenase-1 and cardiovascular disease: mechanisms and therapeutic potential. Clin Sci (Lond) (2011) 0.90
In situ polymerization of tropoelastin in the absence of chemical cross-linking. Biomaterials (2008) 0.90
Tropoelastin as a thermodynamically unfolded premolten globule protein: The effect of trimethylamine N-oxide on structure and coacervation. Arch Biochem Biophys (2009) 0.90
Valve-in-valve implantation for aortic annular rupture complicating transcatheter aortic valve replacement (TAVR). J Invasive Cardiol (2013) 0.89
Coronary microcirculatory resistance is independent of epicardial stenosis. Circ Cardiovasc Interv (2012) 0.89
The fabrication of elastin-based hydrogels using high pressure CO(2). Biomaterials (2008) 0.89
The effect of elastin on chondrocyte adhesion and proliferation on poly (ɛ-caprolactone)/elastin composites. Biomaterials (2010) 0.88
Synthetic human elastin microfibers: stable cross-linked tropoelastin and cell interactive constructs for tissue engineering applications. Acta Biomater (2009) 0.88
Linker-free covalent attachment of the extracellular matrix protein tropoelastin to a polymer surface for directed cell spreading. Acta Biomater (2009) 0.88
HDL-cholesterol, blood pressure, and asymmetric dimethylarginine are significantly associated with arterial wall thickness in children. Arterioscler Thromb Vasc Biol (2009) 0.88
Murine model of wound healing. J Vis Exp (2013) 0.88
Pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension : a systematic review. Ann Thorac Cardiovasc Surg (2011) 0.87
The N-terminal A domain of Staphylococcus aureus fibronectin-binding protein A binds to tropoelastin. Biochemistry (2007) 0.87
Structural changes and facilitated association of tropoelastin. Arch Biochem Biophys (2003) 0.87
High-density lipoproteins augment hypoxia-induced angiogenesis via regulation of post-translational modulation of hypoxia-inducible factor 1α. FASEB J (2013) 0.86
Outcomes of surgical aortic valve replacement in octogenarians. Heart Lung Circ (2013) 0.86
Heparan sulphate interacts with tropoelastin, with some tropoelastin peptides and is present in human dermis elastic fibers. Matrix Biol (2005) 0.86
Flexibility in the solution structure of human tropoelastin. Biochemistry (2007) 0.86
Transient tropoelastin nanoparticles are early-stage intermediates in the coacervation of human tropoelastin whose aggregation is facilitated by heparan sulfate and heparin decasaccharides. Matrix Biol (2009) 0.86